Discovery of Natural Steroid 5 Alpha-Reductase Inhibitors

    Jukkarin Srivilai, Genet Minale, C. Norman Scholfield, Kornkanok Ingkaninan
    Image of study
    TLDR Natural herbal compounds might treat certain medical conditions by reducing DHT levels, but more research is needed to confirm their effectiveness and safety.
    The document from March 1, 2019, reviews the role of steroid 5 alpha-reductase (S5αR) inhibitors in treating conditions like benign prostatic hyperplasia, androgenic alopecia, and acne by reducing dihydrotestosterone (DHT) levels. It points out the limitations and side effects of current synthetic inhibitors like finasteride and dutasteride, suggesting that topical applications could be safer. The document also explores the potential of herbal compounds as natural S5αR inhibitors, noting their traditional uses and the need for robust clinical trials to confirm their efficacy. However, it highlights the wide variability in the potency of these herbal compounds and the need for standardization in testing. The authors recommend systematic screening and standardization of assays, as well as well-designed clinical trials with around 20 participants to develop more effective and specific natural S5αR inhibitors. Despite the potential of herbal compounds, the document concludes that their development into clinically efficacious products has been inconsistent and provides recommendations to improve research in this area.
    Discuss this study in the Community →

    Research cited in this study

    39 / 39 results

    Related Community Posts Join

    6 / 484 results
      FCE 28260: A Forgotten 5α-Reductase Inhibitor

      community FCE 28260: A Forgotten 5α-Reductase Inhibitor

      in Research  330 upvotes 2 months ago
      FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.

      community New and Interesting HairLoss Studies/Papers/Reviews

      in Treatment  44 upvotes 4 years ago
      Hair loss treatments discussed include Dutasteride with Ketoconazole, tissue engineering strategies, and androgenetic alopecia therapies. Massage doubles follicular retention, improving treatment effectiveness.

      community Is this broscience? From More Plates, More Dates

      in Research/Science  22 upvotes 8 months ago
      The conversation discusses whether finasteride's reduction of DHT and increase in scalp testosterone contribute to hair follicle miniaturization. Some participants argue testosterone does not cause miniaturization, while others suggest that even with reduced DHT, other androgens like testosterone may still contribute to hair loss.

      community Why I deleted my YouTube channel Part I

      in Update  118 upvotes 3 years ago
      A YouTuber named Kevin, also known as Rider_Of_Roach, who deleted his YouTube channel due to personal attacks and controversy surrounding his views on hair loss treatments. He advocated for FDA-approved treatments like finasteride and minoxidil but faced backlash from those who disagreed with him. The conversation also discusses his past trolling behavior and a lawsuit he filed against a website that published false information about him. Despite some disagreements, many viewers appreciated his research-based content and hope to see him return in the future.

    Related Research

    2 / 2 results